OA09446A - "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant". - Google Patents

"Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant".

Info

Publication number
OA09446A
OA09446A OA59775A OA59775A OA09446A OA 09446 A OA09446 A OA 09446A OA 59775 A OA59775 A OA 59775A OA 59775 A OA59775 A OA 59775A OA 09446 A OA09446 A OA 09446A
Authority
OA
OAPI
Prior art keywords
ditrimethoxybenzoyl
piperazines
preparation
compositions containing
therapeutic compositions
Prior art date
Application number
OA59775A
Other languages
English (en)
French (fr)
Inventor
Braquet Pierre
Pirotzky Eduardo
Godfroid Jean-Jacques
Heymans Francoise
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of OA09446A publication Critical patent/OA09446A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
OA59775A 1989-04-15 1990-04-12 "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant". OA09446A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898908587A GB8908587D0 (en) 1989-04-15 1989-04-15 New 2-substituted n,n'-ditrimethoxybenzoyl piperazines

Publications (1)

Publication Number Publication Date
OA09446A true OA09446A (fr) 1992-10-15

Family

ID=10655129

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59775A OA09446A (fr) 1989-04-15 1990-04-12 "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant".

Country Status (32)

Country Link
US (1) US5019576A (xx)
JP (1) JP2633709B2 (xx)
KR (1) KR900016178A (xx)
AR (1) AR247736A1 (xx)
AT (1) AT399337B (xx)
AU (1) AU631334B2 (xx)
BE (1) BE1007245A3 (xx)
CA (1) CA2014521C (xx)
CH (1) CH681301A5 (xx)
DE (1) DE4011925A1 (xx)
DK (1) DK91890A (xx)
DZ (1) DZ1407A1 (xx)
ES (1) ES2019554A6 (xx)
FI (1) FI92058C (xx)
FR (2) FR2645743B1 (xx)
GB (2) GB8908587D0 (xx)
GR (1) GR1000355B (xx)
HK (1) HK95092A (xx)
IE (1) IE65058B1 (xx)
IN (1) IN175799B (xx)
IT (1) IT1241631B (xx)
LU (1) LU87719A1 (xx)
MA (1) MA21805A1 (xx)
NL (1) NL9000798A (xx)
NO (1) NO176098C (xx)
NZ (1) NZ233250A (xx)
OA (1) OA09446A (xx)
PT (1) PT93736B (xx)
SE (1) SE505186C2 (xx)
SG (1) SG92092G (xx)
TN (1) TNSN90051A1 (xx)
ZA (1) ZA902566B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5610165A (en) * 1994-02-17 1997-03-11 Merck & Co., Inc. N-acylpiperidine tachykinin antagonists
US5795894A (en) * 1995-05-02 1998-08-18 Schering Corporation Piperazino derivatives as neurokinn antagonists
KR19990008230A (ko) * 1995-05-02 1999-01-25 덜락 노만씨 뉴로키닌 길항제로서의 피페라지노 유도체
US5892039A (en) * 1995-08-31 1999-04-06 Schering Corporation Piperazino derivatives as neurokinin antagonists
BR9610277A (pt) * 1995-08-31 1999-07-06 Schering Corp Derivados de piperazino como antagonistas de neurowuinina
US5869488A (en) * 1996-05-01 1999-02-09 Schering Corporation Piperazino derivatives as neurokinin antagonists
FR2780649B1 (fr) 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
EP0318235A3 (en) * 1987-11-25 1991-05-02 Takeda Chemical Industries, Ltd. Paf antagonist, 1,4-disubstituted piperazine compounds and production thereof
PT90619B (pt) * 1988-05-23 1994-10-31 Glaxo Group Ltd Processo para a preparacao de compostos de piperazina
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
CA2014521A1 (en) 1990-10-15
FI901883A0 (fi) 1990-04-12
FR2645859A1 (fr) 1990-10-19
BE1007245A3 (fr) 1995-05-02
ATA86690A (de) 1994-09-15
GB8908587D0 (en) 1989-06-01
GB2230262B (en) 1992-02-26
IT9020020A0 (it) 1990-04-12
IN175799B (xx) 1995-08-26
GR1000355B (el) 1992-06-25
JPH02292266A (ja) 1990-12-03
SE9001269D0 (sv) 1990-04-06
NO176098B (no) 1994-10-24
AU5326190A (en) 1990-11-01
GR900100270A (en) 1991-09-27
PT93736B (pt) 1996-09-30
IT1241631B (it) 1994-01-25
IT9020020A1 (it) 1991-10-12
SE505186C2 (sv) 1997-07-14
GB9007612D0 (en) 1990-05-30
NO901631L (no) 1990-10-16
FR2645743A1 (fr) 1990-10-19
JP2633709B2 (ja) 1997-07-23
FI92058C (fi) 1994-09-26
US5019576A (en) 1991-05-28
NZ233250A (en) 1991-03-26
DK91890A (da) 1990-10-16
DK91890D0 (da) 1990-04-11
FR2645743B1 (fr) 1992-06-05
PT93736A (pt) 1990-11-20
FR2645859B1 (fr) 1992-06-05
MA21805A1 (fr) 1990-12-31
AT399337B (de) 1995-04-25
DZ1407A1 (fr) 2004-09-13
SG92092G (en) 1992-12-04
CA2014521C (en) 1997-09-09
IE901314L (en) 1990-10-15
ES2019554A6 (es) 1991-06-16
SE9001269L (sv) 1990-10-16
NL9000798A (nl) 1990-11-01
KR900016178A (ko) 1990-11-12
CH681301A5 (xx) 1993-02-26
AU631334B2 (en) 1992-11-19
ZA902566B (en) 1991-01-30
LU87719A1 (fr) 1990-07-24
FI92058B (fi) 1994-06-15
NO901631D0 (no) 1990-04-10
NO176098C (no) 1995-02-01
HK95092A (en) 1992-12-04
AR247736A1 (es) 1995-03-31
DE4011925A1 (de) 1990-10-18
TNSN90051A1 (fr) 1991-03-05
GB2230262A (en) 1990-10-17
IE65058B1 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
DZ2581A1 (fr) Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
OA08647A (fr) Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant.
DZ2753A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant.
CY2537B1 (fr) Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2300A1 (fr) Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr) Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
HUT66863A (en) Process for preparation of oxadiazole and tiadiazole derivatives and pharmaceutical compositions containing them
DZ2416A1 (fr) Dérivés d'acide arylsulfonylhydroxamique procédé pour leur préparation et compositions les contenant.
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
OA09378A (fr) "Nouveaux dérivés de la pipéridine, de la tétrahydropyridine et de la pyrrolidine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
DZ2550A1 (fr) Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1390A1 (fr) Procédé de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïque et de médicaments les contenant.
OA09442A (fr) Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant.
OA09446A (fr) "Dérivés di-substitués des N, N-ditriméthoxybenzoyle pipérazines, un procédé pour leur préparation et compositions thérapeutiques en contenant".
OA09209A (fr) "Dérivés de la thiéno-triazolo-diazépine, un procédé de préparation desdits composés et une composition thérapeutique les contenant".
OA09201A (fr) "Dérivés sulfonyles de la thiéno-triazolo-diazépine, un procédé pour leur préparation et des compositions thérapeutiques en contenant".
FR2707085B1 (fr) Nouveaux dérivés d'alpha amino acides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
OA09336A (fr) Dérivés du glycérol, un procédé de préparation de ces dérivés et des compositions thérapeutiques les contenant.
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
OA08709A (fr) Nouveaux dérivés oxy-5 du tétrahydrofurane, un procédé pour leur préparation et compositions thérapeutiques en contenant.
HU900746D0 (en) Process for preparation of 2,3,23-trihydroxy-urz-12-en and it's derivatives and for pharmaceutical compositions containing that compounds
FR2691461B1 (fr) Dérivés de cycloheptimidazole, procédé pour les préparer et composition pharmaceutique et agents thérapeutiques les contenant.